https://bidda.com/intelligence/category/pharma2026-06-07 https://bidda.com/intelligence/australia-tga-austl-r-medicine-registration2026-04-24 https://bidda.com/intelligence/australia-tga-therapeutic-goods-act-19892026-04-30 https://bidda.com/intelligence/br-law-6360-1976-anvisa-drug-registration2026-05-30T00:00:00Z https://bidda.com/intelligence/brazil-anvisa-good-manufacturing-practices-rdc-658-20222026-05-09 https://bidda.com/intelligence/brazil-anvisa-resolution-rdc-204-20172026-04-30 https://bidda.com/intelligence/ca-food-drugs-act-19852019-05-09 https://bidda.com/intelligence/ca-food-drugs-act-part-c-drugs-therapeutic2026-05-06 https://bidda.com/intelligence/canada-clinical-trials-division-5-c02-2622026-04-24 https://bidda.com/intelligence/canada-food-drug-regulations-division-5-clinical-trials2026-04-30 https://bidda.com/intelligence/canada-natural-health-products-regulations-2003-nhpr2026-05-09 https://bidda.com/intelligence/canada-pmprb-patented-medicine-prices-20212026-04-30 https://bidda.com/intelligence/china-nmpa-drug-registration-regulation-20202026-05-09 https://bidda.com/intelligence/eu-advanced-therapy-medicinal-products-2007-13942026-04-30 https://bidda.com/intelligence/eu-atmp-regulation-1394-2007-advanced-therapies2026-04-30 https://bidda.com/intelligence/eu-atmp-regulation-1394-pharma-gene-cell2026-04-21 https://bidda.com/intelligence/eu-biosimilars-guideline-ema-20142026-04-30 https://bidda.com/intelligence/eu-clinical-trials-eu-ctr-trials-regulation2026-04-21 https://bidda.com/intelligence/eu-clinical-trials-regulation-2014-536-ctr-investigational-medicinal-products2026-01-01 https://bidda.com/intelligence/eu-clinical-trials-regulation-536-2014-ctr-investigational-medicinal-products2024-01-31 https://bidda.com/intelligence/eu-ema-centralised-procedure-regulation-726-20042026-04-30 https://bidda.com/intelligence/eu-ema-prime-scheme-priority-medicines2026-04-30 https://bidda.com/intelligence/eu-falsified-medicines-directive-2011-62-ec2026-04-21 https://bidda.com/intelligence/eu-falsified-medicines-directive-2011-62-eu-serialisation-track-trace2024-01-01 https://bidda.com/intelligence/eu-fmd-delegated-regulation-2016-161-safety-features2026-04-26 https://bidda.com/intelligence/eu-gmp-annex-1-sterile-manufacture-20222026-04-30 https://bidda.com/intelligence/eu-gmp-annex-3-radiopharmaceuticals2026-05-31 https://bidda.com/intelligence/eu-good-distribution-practice-gdp-guidelines-20132026-04-26 https://bidda.com/intelligence/eu-good-manufacturing-practice-gdp-2013-c-343-4-medicinal-products2026-05-10 https://bidda.com/intelligence/eu-herbal-medicinal-products-directive-2004-242026-04-30 https://bidda.com/intelligence/eu-ivdr-2017-746-in-vitro-diagnostic-devices2026-04-20 https://bidda.com/intelligence/eu-medical-devices-regulation-mdr-2017-745-implementation2026-04-21 https://bidda.com/intelligence/eu-medicinal-products-directive-2001-83-ec2026-04-21 https://bidda.com/intelligence/eu-medicinal-products-human-directive-2001-832022-01-13 https://bidda.com/intelligence/eu-orphan-regulation-141-2000-designation-criteria2026-04-30 https://bidda.com/intelligence/eu-paediatric-regulation-1901-2006-pharma2026-04-30 https://bidda.com/intelligence/eu-paediatric-regulation-1901-2006-pip-paediatric-investigation-plan2024-01-01 https://bidda.com/intelligence/eu-paediatric-regulation-1901-2006-pips2026-04-30 https://bidda.com/intelligence/eu-pharma-gcp-directive-2005-28-clinical-trials-conduct2026-05-09 https://bidda.com/intelligence/eu-pharma-regulation-2022-0134-article-5-marketing-authorisation2026-05-09 https://bidda.com/intelligence/eu-pharmacovigilance-directive-2010-84-eu2026-04-21 https://bidda.com/intelligence/eu-pharmacovigilance-regulation-1235-2010-psur2026-04-20 https://bidda.com/intelligence/fda-21-cfr-210-211-current-good-manufacturing-practice2026-04-30 https://bidda.com/intelligence/fda-21-cfr-part-312-ind-investigational-new-drug2026-04-20 https://bidda.com/intelligence/fda-21-cfr-part-314-nda-new-drug-application2026-04-30 https://bidda.com/intelligence/fda-21-cfr-part-600-601-biologics-licensing2026-04-30 https://bidda.com/intelligence/fda-21st-century-cures-act-digital-health-provisions2026-04-30 https://bidda.com/intelligence/fda-adaptive-clinical-trial-design-guidance-20192026-04-30 https://bidda.com/intelligence/fda-biosimilar-pathway-351k-biologics-competition-act2026-04-30 https://bidda.com/intelligence/fda-breakthrough-therapy-designation-guidance-20182026-04-30 https://bidda.com/intelligence/fda-pdufa-vii-goals-letter-20222026-04-30 https://bidda.com/intelligence/fda-real-world-evidence-program-guidance-20182026-04-20 https://bidda.com/intelligence/gh-food-and-drugs-authority-act-1992-pndc-law-305b2026-05-30T00:00:00Z https://bidda.com/intelligence/ich-e11-r1-clinical-investigation-pediatric-population2026-05-31 https://bidda.com/intelligence/ich-e2e-pharmacovigilance-planning-20042004-11-18 https://bidda.com/intelligence/ich-e6-r3-good-clinical-practice-pharma-20232026-04-30 https://bidda.com/intelligence/ich-e8-r1-general-considerations-clinical-studies-20212026-04-30 https://bidda.com/intelligence/ich-e9-r1-estimands-sensitivity-analysis-pharma-20192026-04-30 https://bidda.com/intelligence/ich-m12-drug-interaction-studies-20232026-04-30 https://bidda.com/intelligence/ich-m3-r2-nonclinical-safety-studies2026-05-31 https://bidda.com/intelligence/ich-m4-common-technical-document-20022016-11-01 https://bidda.com/intelligence/ich-m7-r1-mutagenic-impurities-20172026-04-30 https://bidda.com/intelligence/ich-q10-pharmaceutical-quality-system2026-04-30 https://bidda.com/intelligence/ich-q10-pharmaceutical-quality-system-lifecycle-management2023-06-01 https://bidda.com/intelligence/ich-q11-drug-substance-development-manufacture2026-04-30 https://bidda.com/intelligence/ich-q12-pharmaceutical-product-lifecycle-management2026-04-30 https://bidda.com/intelligence/ich-q13-continuous-manufacturing-20222026-04-30 https://bidda.com/intelligence/ich-q14-analytical-procedure-development-20232023-11-07 https://bidda.com/intelligence/ich-q2-r2-validation-analytical-procedures-20222022-11-16 https://bidda.com/intelligence/ich-q3a-r2-impurities-new-drug-substances2026-05-31 https://bidda.com/intelligence/ich-q3b-r2-impurities-new-drug-products2026-05-31 https://bidda.com/intelligence/ich-q4b-pharmacopoeial-texts2026-05-31 https://bidda.com/intelligence/ich-q5e-comparability-biotech-products2026-05-31 https://bidda.com/intelligence/ich-q9-r1-quality-risk-management-pharma-20232026-04-20 https://bidda.com/intelligence/ich-q9-r1-quality-risk-management-pharmaceutical2026-05-13 https://bidda.com/intelligence/ich-s2-r1-genotoxicity-testing-data-interpretation2026-05-31 https://bidda.com/intelligence/ich-s9-nonclinical-anticancer-pharmaceutical-20102026-04-20 https://bidda.com/intelligence/id-bpom-drug-registration-regulations-badan-pengawas-obat-makanan2026-05-30T00:00:00Z https://bidda.com/intelligence/india-drugs-cosmetics-act-1940-cdsco2026-05-09 https://bidda.com/intelligence/iso-13485-2016-medical-devices-quality-management2026-04-20 https://bidda.com/intelligence/iso-14644-1-2015-cleanrooms-classification2026-04-30 https://bidda.com/intelligence/japan-pmda-pharmaceutical-affairs-law2026-04-21 https://bidda.com/intelligence/jp-pharmaceutical-medical-devices-act-20142020-09-01 https://bidda.com/intelligence/mx-ley-general-de-salud-cofepris-pharmaceutical-regulation2026-05-30T00:00:00Z https://bidda.com/intelligence/oecd-good-laboratory-practice-principles-revised-19972026-04-30 https://bidda.com/intelligence/sa-sfda-pharmaceutical-regulations-saudi-food-drug-authority2026-05-30T00:00:00Z https://bidda.com/intelligence/sg-health-products-act-part-ii-market-approval2026-05-06 https://bidda.com/intelligence/singapore-hsa-therapeutic-products-act-20162026-04-20 https://bidda.com/intelligence/south-korea-mfds-pharmaceutical-act-20232026-05-09 https://bidda.com/intelligence/uk-human-medicines-regulations-20122023-01-01 https://bidda.com/intelligence/uk-human-medicines-regulations-2012-si-19162026-04-20 https://bidda.com/intelligence/uk-mhra-good-clinical-practice-regulations-20042026-04-30 https://bidda.com/intelligence/us-21-cfr-part-1308-dea-schedules-controlled-substances2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-207-drug-establishment-registration2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-210-cgmp-general-provisions2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-211-cgmp-finished-pharmaceuticals2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-312-investigational-new-drug2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-314-applications-fda-approval-new-drug2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-320-bioavailability-bioequivalence2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-50-protection-human-subjects2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-56-institutional-review-boards2026-05-31 https://bidda.com/intelligence/us-21-cfr-part-600-biological-products-general2026-05-31 https://bidda.com/intelligence/us-controlled-substances-act2026-05-26 https://bidda.com/intelligence/us-controlled-substances-act-21-usc-ch132026-05-28 https://bidda.com/intelligence/us-dea-21-cfr-1301-1308-controlled-substances-registration-manufacturing2024-01-01 https://bidda.com/intelligence/us-dea-21-cfr-1308-controlled-substances-schedules2026-05-24 https://bidda.com/intelligence/us-dscsa-2013-drug-supply-chain-security-act2026-04-30 https://bidda.com/intelligence/us-fda-21-cfr-203-prescription-drug-marketing2026-05-24 https://bidda.com/intelligence/us-fda-21-cfr-205-wholesale-drug-distribution-licensing2026-05-24 https://bidda.com/intelligence/us-fda-21-cfr-211-cgmp-finished-pharmaceuticals2026-04-21 https://bidda.com/intelligence/us-fda-21-cfr-312-ind-application2026-04-21 https://bidda.com/intelligence/us-fda-21-cfr-312-ind-application-investigational-new-drug2024-03-01 https://bidda.com/intelligence/us-fda-21-cfr-314-nda-application2026-04-21 https://bidda.com/intelligence/us-fda-21-cfr-320-bioavailability-bioequivalence-requirements2026-05-25 https://bidda.com/intelligence/us-fda-21-cfr-600-biological-products-general-standards2026-05-24 https://bidda.com/intelligence/us-fda-21-cfr-part-11-electronic-records-signatures2026-05-09 https://bidda.com/intelligence/us-fda-amendments-act-2007-fdaaa-pl-110-852026-05-30T00:00:00Z https://bidda.com/intelligence/us-fda-cfr-21-part-11-electronic-records2026-05-06 https://bidda.com/intelligence/us-fda-cfr-21-part-11-electronic-records-signatures2026-05-06 https://bidda.com/intelligence/us-fda-cfr-21-part-312-ind-application2026-05-06 https://bidda.com/intelligence/us-fda-cfr-21-part-314-new-drug-applications2026-05-06 https://bidda.com/intelligence/us-fda-combination-products-21-cfr-32026-04-30 https://bidda.com/intelligence/us-fda-modernization-act-1997-pl-105-1152026-05-28T00:00:00Z https://bidda.com/intelligence/us-fda-real-world-evidence-programme-pharma2026-04-30 https://bidda.com/intelligence/us-fdca-food-drug-cosmetic-act-21-usc-3012026-05-28 https://bidda.com/intelligence/us-federal-food-drug-and-cosmetic-act2026-05-26 https://bidda.com/intelligence/us-orphan-drug-act2026-05-27 https://bidda.com/intelligence/us-orphan-drug-act-1983-rare-diseases2026-04-30 https://bidda.com/intelligence/us-orphan-drug-act-1983-section-526-designation2026-04-30 https://bidda.com/intelligence/us-pdufa-prescription-drug-user-fee-act2026-04-30 https://bidda.com/intelligence/who-gmp-good-manufacturing-practices-20212026-04-30